Showing results (31-40 of 238) with videos related to
Sort By:
Pageof 24
Nature Reviews. Clinical Oncology|October 27, 2010
Translating p53 into the clinicChit Fang Cheok, Chandra S Verma, José Baselga, et al.Journal of Proteomics|May 17, 2012
Batch effects correction improves the sensitivity of significance tests in spectral counting-based comparative discovery proteomicsJosep Gregori, Laura Villarreal, Olga Méndez, et al.Molecular & Cellular Proteomics : MCP|December 28, 2012
Unconventional secretion is a major contributor of cancer cell line secretomesLaura Villarreal, Olga Méndez, Cándida Salvans, et al.Nature Communications|February 1, 2017
Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programsHatice U Osmanbeyoglu, Eneda Toska, Carmen Chan, et al.Seminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.Lung Cancer (Amsterdam, Netherlands)|June 11, 2011
Tissue sampling in lung cancer: a review in light of the MERIT experienceMartin Reck, Andreas Hermes, Eng-Huat Tan, et al.Elife|January 27, 2016
The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epitheliumJoaquim Grego-Bessa, Joshua Bloomekatz, Pau Castel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancerSiân Lennon, Claire Barton, Ludger Banken, et al.Pharmacology & Therapeutics|December 10, 2015
AKT signaling in ERBB2-amplified breast cancerF Javier Carmona, Filippo Montemurro, Srinivasaraghavan Kannan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancerJosé Baselga, Javier Cortés, Seock-Ah Im, et al.Pageof 24